[go: up one dir, main page]

NO992062L - Preparation for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Preparation for the treatment of asthma, containing loratadine and a decongestant

Info

Publication number
NO992062L
NO992062L NO992062A NO992062A NO992062L NO 992062 L NO992062 L NO 992062L NO 992062 A NO992062 A NO 992062A NO 992062 A NO992062 A NO 992062A NO 992062 L NO992062 L NO 992062L
Authority
NO
Norway
Prior art keywords
asthma
decongestant
preparation
treatment
containing loratadine
Prior art date
Application number
NO992062A
Other languages
Norwegian (no)
Other versions
NO992062D0 (en
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO992062L publication Critical patent/NO992062L/en
Publication of NO992062D0 publication Critical patent/NO992062D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En fremgangsmåte for forbedring av lungefunksjon hos en pasient som lider av astma,¿omfattende at det til pasien- ten administreres vanlige rhinitt- behandlingseffektive mengder av lora- tadin og et dekongestionsmiddel, slik som pseudoefedrin.A method of improving lung function in a patient suffering from asthma, comprising administering to the patient normal rhinitis treatment effective amounts of lorathadine and a decongestant agent such as pseudoephedrine.

NO992062A 1996-10-31 1999-04-29 Preparation for the treatment of asthma, containing loratadine and a decongestant NO992062D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (2)

Publication Number Publication Date
NO992062L true NO992062L (en) 1999-04-29
NO992062D0 NO992062D0 (en) 1999-04-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992062A NO992062D0 (en) 1996-10-31 1999-04-29 Preparation for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
PA8481801A1 (en) * 1998-09-10 2000-09-29 Schering Corp METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING ANTIHISTAMINES
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
ATE253354T1 (en) * 1999-02-23 2003-11-15 Yuhan Corp CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
JP5592042B2 (en) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド Single dose antihistamine / decongestant formulation for the treatment of rhinitis
BR0111018A (en) * 2000-05-25 2004-02-17 Schering Corp Liquid and solid stable formulations
MXPA03011705A (en) * 2001-06-20 2004-03-19 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction.
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
NZ575838A (en) 2005-06-17 2010-10-29 Aft Pharmaceuticals Ltd Composition comprising loratadine and phenylephrine and its use in a method for treatment of patients with upper respiratory mucosal congestion
CN104161736A (en) * 2006-06-01 2014-11-26 Msd消费保健品公司 Sustained release pharmaceutical dosage form containing phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
PL333056A1 (en) 1999-11-08
JP2000505104A (en) 2000-04-25
EP0941091A1 (en) 1999-09-15
BR9712705A (en) 1999-10-26
SK54599A3 (en) 2000-08-14
CZ150999A3 (en) 1999-10-13
TR199901003T2 (en) 1999-07-21
AU4995397A (en) 1998-05-22
AR008908A1 (en) 2000-02-23
PE11399A1 (en) 1999-02-09
KR20000052922A (en) 2000-08-25
CO4910128A1 (en) 2000-04-24
CA2268546A1 (en) 1998-05-07
WO1998018470A1 (en) 1998-05-07
HUP9904075A3 (en) 2002-02-28
CN1235545A (en) 1999-11-17
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (en) 2000-04-20
NO992062D0 (en) 1999-04-29
HUP9904075A2 (en) 2000-05-28
IL129662A0 (en) 2000-02-29
ZA979731B (en) 1998-04-29

Similar Documents

Publication Publication Date Title
NO992062L (en) Preparation for the treatment of asthma, containing loratadine and a decongestant
NO972475L (en) New antithrombotic formulation, process for its preparation and use thereof
NO20004915D0 (en) Transdermal Therapeutic System Containing a D2 Agonist for the Treatment of Parkinson's Syndrome, and a Method for Its Preparation
IS2788B (en) Budesonide / formoterol formulation for inhalation at a free concentration of 0.30 to 0.36 g / ml, method of preparation and use of the preparation
NO983641L (en) METHOD OF TREATMENT AND PHARMACEUTICAL PREPARATION
IS4509A (en) Inhalation device, method of dispensing pharmaceutically active substance and method of administering a dose of pharmaceutically active substance
NO20010844L (en) Regulation of substrate activity
NO993847L (en) Methods and Preparations for the Treatment of Allergic Asthma and Other Diseases Using Descarboethoxyloratadine
NO20040968L (en) Opioid agonist preparations with releasable and sequestered antagonist
HK1044119A1 (en) Treating sleep disorders using desloratadine
MY116091A (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
NZ334270A (en) Glucagon like peptide (GLP-1), analogs and derivatives to treat post surgical catabolic changes and insulin resistance
EE04800B1 (en) Oral dosage form for acid unstable active ingredient, unit dosage form, method of preparation and use, and method for oral dosage form
ES2168302T3 (en) TREATMENT OF DISORDERS AND NEUROMUSCULAR STATES WITH SEROTYPE BOTULIN TOXIN E.
AU2002224914A1 (en) Method and device for the diagnosis and therapy of chronic heart failure
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
SE9603725D0 (en) New teatment
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
NO880434D0 (en) ANESTHETIC PREPARATIONS AND PROCEDURES FOR USE THEREOF.
DK0804229T3 (en) Use of amlodipine, a salt thereof, or felodipine in combination with an ACE inhibitor for the manufacture of a medicament for the treatment of non-ischemic congestive heart failure
NO20083276L (en) Treatment of diabetes with thiazolidinedione and sulfonylurea
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
NO984446L (en) Procedure for treating pain
SE9902597D0 (en) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application